Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation

Introduction Recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT) carries a poor prognosis. The aim of our study was to assess the safety and efficacy of sorafenib in patients with recurrent HCC following LT. Methods A prospectively maintained LT database was retrospectively...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical transplantation 2013-07, Vol.27 (4), p.555-561
Hauptverfasser:	Waghray, Abhijeet, Balci, Bengi, El-Gazzaz, Galal, Kim, Richard, Pelley, Robert, Narayanan Menon, KV, Estfan, Bassam, Romero-Marrero, Carlos, Aucejo, Federico
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - surgery Female Follow-Up Studies Fundamental and applied biological sciences. Psychology Fundamental immunology Gastroenterology. Liver. Pancreas. Abdomen hepatocellular carcinoma Humans Liver Neoplasms - drug therapy Liver Neoplasms - pathology Liver Neoplasms - surgery Liver Transplantation Liver, biliary tract, pancreas, portal circulation, spleen Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences MELD Middle Aged Milan criteria Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - pathology Niacinamide - analogs & derivatives Niacinamide - therapeutic use Phenylurea Compounds - therapeutic use Postoperative Complications Prognosis Prospective Studies Protein Kinase Inhibitors - therapeutic use Retrospective Studies sorafenib Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the digestive system Tissue, organ and graft immunology Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!